KOSDAQ · 352770 · Biotech & Pharma · ₩352770

Celestra셀레스트라

352770 · KOSDAQ · ₩352770 · 셀레스트라

₩5,250 ₩0 (0.00%)End-of-day · Oct 29, 2026 · End-of-day prices.

Trade

Sell Buy

Filings

Change of Head Office Location본점소재지변경Sep 23, 2026Open on DART
Market Notice (No Market Measures Yet Taken Regarding Rehabilitation Procedure Termination Decision)기타시장안내 (회생절차 폐지결정 관련 시장조치 미진행)Aug 24, 2026Open on DART
Decision to Terminate Rehabilitation Procedure회생절차폐지결정Aug 24, 2026Open on DART
Other Market Notice (Non-Implementation of Procedures Following Addition of Grounds for Substantive Review of Listing Eligibility)기타시장안내 (상장적격성 실질심사 사유 추가 관련 절차 미진행)Aug 14, 2026Open on DART
Confirmation of Facts Such as Adverse Opinion on Semi-annual Review (Audit), Including Capital Impairment Ratio of 50% or More or Equity Under ₩1B반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)Aug 14, 2026Open on DART
Occurrence of Semi-Annual or Quarterly Revenue Shortfall반기또는분기매출액미달사실발생Aug 14, 2026Open on DART
Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
[Amended] Commencement of Rehabilitation Proceedings Decision[기재정정]회생절차개시결정Jun 11, 2026Open on DART
Trading halt주권매매거래정지 (투자자 보호)Jun 9, 2026Open on DART
Other Market Notice (Regarding Postponement of Clearance Sale)기타시장안내 (정리매매 보류 관련)Jun 9, 2026Open on DART
Other management matters기타경영사항(자율공시) (상장폐지결정등 효력정지 가처분 신청)Jun 9, 2026Open on DART
Other Market Notice (Results of Deliberation by Corporate Review Committee)기타시장안내 (기업심사위원회 심의·의결 결과 안내)Jun 8, 2026Open on DART
Delisting주권매매거래정지해제 (상장폐지에 따른 정리매매 개시)Jun 8, 2026Open on DART
Market Notice (Guidance on Deadline for Decision Subject to Substantive Review of Listing Eligibility)기타시장안내 (상장적격성 실질심사 대상결정 기한 안내 )May 18, 2026Open on DART
Other Market Notice (Related to Substantive Review of Listing Eligibility)기타시장안내 (상장적격성 실질심사 관련)May 15, 2026Open on DART
Trading halt주권매매거래정지기간변경 (상장적격성 실질심사 대상(사유발생))May 15, 2026Open on DART
Occurrence of Semi-Annual or Quarterly Revenue Shortfall반기또는분기매출액미달사실발생May 15, 2026Open on DART
Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
[Amended] Commencement of Rehabilitation Proceedings Decision[기재정정]회생절차개시결정May 14, 2026Open on DART
Other Market Notice (Guidance on Submission of Improvement Plan Implementation Report)기타시장안내 (개선계획 이행내역서 제출에 따른 안내)May 12, 2026Open on DART
Delisting기타시장안내 (상장폐지 관련 이의신청서 접수)Apr 28, 2026Open on DART
[Amended] Commencement of Rehabilitation Proceedings Decision[기재정정]회생절차개시결정Apr 21, 2026Open on DART
Delisting기타시장안내 (개선기간 종료에 따른 상장폐지 여부 결정 안내)Apr 17, 2026Open on DART
Delisting주권매매거래정지기간변경 (상장폐지 사유 발생)Apr 7, 2026Open on DART
Delisting기타시장안내 (상장폐지 관련)Apr 7, 2026Open on DART
Audit report submitted감사보고서제출Apr 7, 2026Open on DART
Annual report (Dec 2025)사업보고서 (2025.12)Apr 7, 2026Open on DART
[Amended] Commencement of Rehabilitation Proceedings Decision[기재정정]회생절차개시결정Mar 24, 2026Open on DART
Audit report submitted기타경영사항(자율공시) (감사보고서 제출 지연)Mar 24, 2026Open on DART
Annual report (Dec 2025)사업보고서제출기한연장신고서 (2025.12)Mar 24, 2026Open on DART
[Amended] Commencement of Rehabilitation Proceedings Decision[기재정정]회생절차개시결정Feb 11, 2026Open on DART
[Amended] Commencement of Rehabilitation Proceedings Decision[기재정정]회생절차개시결정Dec 23, 2025Open on DART
Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 15, 2025Open on DART
[Amended] Commencement of Rehabilitation Proceedings Decision[기재정정]회생절차개시결정Dec 9, 2025Open on DART
Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
Trading halt주권매매거래정지기간변경 (파산신청)Nov 3, 2025Open on DART
Bankruptcy Petition Filed파산신청Nov 3, 2025Open on DART
[Amended] Commencement of Rehabilitation Proceedings Decision[기재정정]회생절차개시결정Oct 27, 2025Open on DART
Trading halt주권매매거래정지기간변경 (회생절차 개시결정)Sep 30, 2025Open on DART
Commencement of Court Rehabilitation Procedures회생절차개시결정Sep 30, 2025Open on DART
Change of Head Office Location본점소재지변경Sep 25, 2025Open on DART
Results of Extraordinary Shareholders' Meeting임시주주총회결과Sep 25, 2025Open on DART
Amended: Shareholders' meeting called[기재정정]주주총회소집결의 (임시주주총회)Sep 25, 2025Open on DART
Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Sep 25, 2025Open on DART
[Amended Filing] Major Matters Report (Application for Commencement of Corporate Rehabilitation)[기재정정]주요사항보고서(회생절차개시신청)Sep 10, 2025Open on DART
Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Sep 10, 2025Open on DART
Notice of shareholders' meeting주주총회소집공고Sep 10, 2025Open on DART
Trading halt주권매매거래정지기간변경 (회생절차 개시신청)Sep 8, 2025Open on DART
Material Matters Report (Commencement of Rehabilitation Proceedings Application)주요사항보고서(회생절차개시신청)Sep 8, 2025Open on DART
Confirmation of Facts Such as Adverse Opinion on Semi-annual Review (Audit), Including Capital Impairment Ratio of 50% or More or Equity Under ₩1B반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)Aug 14, 2025Open on DART

Titles in Korean until English translations are added.

Also known as: Celestra / 셀레스트라 / 352770 / KRX:352770

Source: KRX statistical information